{"id":"https://openalex.org/W7204028830","doi":"https://doi.org/10.1016/j.jconrel.2026.115275","title":"Nanoparticles-mediated dual drug administration boosts therapeutic efficacy in drug resistant melanoma","display_name":"Nanoparticles-mediated dual drug administration boosts therapeutic efficacy in drug resistant melanoma","publication_year":2026,"publication_date":"2026-08-23","ids":{"openalex":"https://openalex.org/W7204028830","doi":"https://doi.org/10.1016/j.jconrel.2026.115275","pmid":"https://pubmed.ncbi.nlm.nih.gov/42633845"},"language":"en","primary_location":{"id":"doi:10.1016/j.jconrel.2026.115275","doi":"https://doi.org/10.1016/j.jconrel.2026.115275","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jconrel.2026.115275","pdf_url":"https://www.sciencedirect.com/science/article/pii/S0168365926006796/pdf","source":{"id":"https://openalex.org/S161954266","display_name":"Journal of Controlled Release","issn_l":"0168-3659","issn":["0168-3659","1873-4995"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Controlled Release","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.sciencedirect.com/science/article/pii/S0168365926006796/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Giulia Lovati","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]},{"id":"https://openalex.org/I93860229","display_name":"Politecnico di Milano","ror":"https://ror.org/01nffqt88","country_code":"IT","type":"education","lineage":["https://openalex.org/I93860229"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giulia Lovati","raw_affiliation_strings":["Department of Experimental Oncology, European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milano, Italy; Laboratory of Innovative approaches for tissue engineering and drug delivery Joint Research Platform \"ONCO-TECH LAB - Modeling and Applications for Human Health\", Politecnico di Milano - European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Experimental Oncology, European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milano, Italy; Laboratory of Innovative approaches for tissue engineering and drug delivery Joint Research Platform \"ONCO-TECH LAB - Modeling and Applications for Human Health\", Politecnico di Milano - European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milano, Italy","institution_ids":["https://openalex.org/I6141010","https://openalex.org/I93860229"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5092115476","display_name":"Pietro Milesi","orcid":"https://orcid.org/0009-0005-5452-7435","observed_orcids":["https://orcid.org/0009-0005-5452-7435"]},"institutions":[{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]},{"id":"https://openalex.org/I93860229","display_name":"Politecnico di Milano","ror":"https://ror.org/01nffqt88","country_code":"IT","type":"education","lineage":["https://openalex.org/I93860229"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Pietro Milesi","raw_affiliation_strings":["Department of Chemistry, Materials, and Chemical Engineering \"Giulio Natta\", Politecnico di Milano, Via E. Bassini 6, 20133 Milano, Italy; Laboratory of Innovative approaches for tissue engineering and drug delivery Joint Research Platform \"ONCO-TECH LAB - Modeling and Applications for Human Health\", Politecnico di Milano - European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Materials, and Chemical Engineering \"Giulio Natta\", Politecnico di Milano, Via E. Bassini 6, 20133 Milano, Italy; Laboratory of Innovative approaches for tissue engineering and drug delivery Joint Research Platform \"ONCO-TECH LAB - Modeling and Applications for Human Health\", Politecnico di Milano - European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milano, Italy","institution_ids":["https://openalex.org/I6141010","https://openalex.org/I93860229"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5147888664","display_name":"Paolo Fossati","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]},{"id":"https://openalex.org/I93860229","display_name":"Politecnico di Milano","ror":"https://ror.org/01nffqt88","country_code":"IT","type":"education","lineage":["https://openalex.org/I93860229"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Paolo Fossati","raw_affiliation_strings":["Department of Experimental Oncology, European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milano, Italy; Department of Chemistry, Materials, and Chemical Engineering \"Giulio Natta\", Politecnico di Milano, Via E. Bassini 6, 20133 Milano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Experimental Oncology, European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milano, Italy; Department of Chemistry, Materials, and Chemical Engineering \"Giulio Natta\", Politecnico di Milano, Via E. Bassini 6, 20133 Milano, Italy","institution_ids":["https://openalex.org/I6141010","https://openalex.org/I93860229"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038253944","display_name":"Daria Duca","orcid":"https://orcid.org/0000-0001-6049-5867","observed_orcids":["https://orcid.org/0000-0001-6049-5867"]},"institutions":[{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Daria Duca","raw_affiliation_strings":["Department of Experimental Oncology, European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Experimental Oncology, European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milano, Italy","institution_ids":["https://openalex.org/I6141010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5147879182","display_name":"Federica Maria Prandini","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]},{"id":"https://openalex.org/I93860229","display_name":"Politecnico di Milano","ror":"https://ror.org/01nffqt88","country_code":"IT","type":"education","lineage":["https://openalex.org/I93860229"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Federica Maria Prandini","raw_affiliation_strings":["Department of Experimental Oncology, European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milano, Italy; Department of Chemistry, Materials, and Chemical Engineering \"Giulio Natta\", Politecnico di Milano, Via E. Bassini 6, 20133 Milano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Experimental Oncology, European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milano, Italy; Department of Chemistry, Materials, and Chemical Engineering \"Giulio Natta\", Politecnico di Milano, Via E. Bassini 6, 20133 Milano, Italy","institution_ids":["https://openalex.org/I6141010","https://openalex.org/I93860229"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103847640","display_name":"Luca Brambilla","orcid":"https://orcid.org/0000-0003-0825-2141","observed_orcids":["https://orcid.org/0000-0003-0825-2141"]},"institutions":[{"id":"https://openalex.org/I93860229","display_name":"Politecnico di Milano","ror":"https://ror.org/01nffqt88","country_code":"IT","type":"education","lineage":["https://openalex.org/I93860229"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Luca Brambilla","raw_affiliation_strings":["Department of Chemistry, Materials, and Chemical Engineering \"Giulio Natta\", Politecnico di Milano, Via E. Bassini 6, 20133 Milano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Materials, and Chemical Engineering \"Giulio Natta\", Politecnico di Milano, Via E. Bassini 6, 20133 Milano, Italy","institution_ids":["https://openalex.org/I93860229"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090619004","display_name":"Lodovico Gatti","orcid":"https://orcid.org/0000-0003-4793-6976","observed_orcids":["https://orcid.org/0000-0003-4793-6976"]},"institutions":[{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Lodovico Gatti","raw_affiliation_strings":["Department of Experimental Oncology, European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Experimental Oncology, European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milano, Italy","institution_ids":["https://openalex.org/I6141010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069094532","display_name":"Erika Mileti","orcid":"https://orcid.org/0000-0003-0425-5169","observed_orcids":["https://orcid.org/0000-0003-0425-5169"]},"institutions":[{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Erika Mileti","raw_affiliation_strings":["Department of Experimental Oncology, European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Experimental Oncology, European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milano, Italy","institution_ids":["https://openalex.org/I6141010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079200408","display_name":"Giuseppina Giardina","orcid":"https://orcid.org/0009-0009-6833-5636","observed_orcids":["https://orcid.org/0009-0009-6833-5636"]},"institutions":[{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giuseppina Giardina","raw_affiliation_strings":["Department of Experimental Oncology, European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Experimental Oncology, European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milano, Italy","institution_ids":["https://openalex.org/I6141010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073541194","display_name":"Mirko Doni","orcid":"https://orcid.org/0000-0001-7099-2701","observed_orcids":["https://orcid.org/0000-0001-7099-2701"]},"institutions":[{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Mirko Doni","raw_affiliation_strings":["Department of Experimental Oncology, European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Experimental Oncology, European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milano, Italy","institution_ids":["https://openalex.org/I6141010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073802845","display_name":"Mattia Tiboni","orcid":"https://orcid.org/0000-0002-3953-4937","observed_orcids":["https://orcid.org/0000-0002-3953-4937"]},"institutions":[{"id":"https://openalex.org/I190397597","display_name":"University of Urbino","ror":"https://ror.org/04q4kt073","country_code":"IT","type":"education","lineage":["https://openalex.org/I190397597"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Mattia Tiboni","raw_affiliation_strings":["Department of Biomolecular Sciences, University of Urbino Carlo Bo, Urbino, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biomolecular Sciences, University of Urbino Carlo Bo, Urbino, Italy","institution_ids":["https://openalex.org/I190397597"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076642853","display_name":"Luca Casettari","orcid":"https://orcid.org/0000-0001-6907-8904","observed_orcids":["https://orcid.org/0000-0001-6907-8904"]},"institutions":[{"id":"https://openalex.org/I190397597","display_name":"University of Urbino","ror":"https://ror.org/04q4kt073","country_code":"IT","type":"education","lineage":["https://openalex.org/I190397597"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Luca Casettari","raw_affiliation_strings":["Department of Biomolecular Sciences, University of Urbino Carlo Bo, Urbino, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biomolecular Sciences, University of Urbino Carlo Bo, Urbino, Italy","institution_ids":["https://openalex.org/I190397597"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5136403890","display_name":"Martina Beccalli","orcid":"https://orcid.org/0009-0003-7341-0027","observed_orcids":["https://orcid.org/0009-0003-7341-0027"]},"institutions":[{"id":"https://openalex.org/I93860229","display_name":"Politecnico di Milano","ror":"https://ror.org/01nffqt88","country_code":"IT","type":"education","lineage":["https://openalex.org/I93860229"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Martina Beccalli","raw_affiliation_strings":["Department of Chemistry, Materials, and Chemical Engineering \"Giulio Natta\", Politecnico di Milano, Via E. Bassini 6, 20133 Milano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Materials, and Chemical Engineering \"Giulio Natta\", Politecnico di Milano, Via E. Bassini 6, 20133 Milano, Italy","institution_ids":["https://openalex.org/I93860229"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111304097","display_name":"Giovanna Jodice","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giovanna Jodice","raw_affiliation_strings":["Department of Experimental Oncology, European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Experimental Oncology, European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milano, Italy","institution_ids":["https://openalex.org/I6141010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024763432","display_name":"Massimo C.P. Barberis","orcid":"https://orcid.org/0000-0002-0943-4804","observed_orcids":["https://orcid.org/0000-0002-0943-4804"]},"institutions":[{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Massimo Barberis","raw_affiliation_strings":["Department of Experimental Oncology, European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Experimental Oncology, European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milano, Italy","institution_ids":["https://openalex.org/I6141010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113313598","display_name":"Andrea Francesco Benvenuto","orcid":"https://orcid.org/0009-0007-9859-2188","observed_orcids":["https://orcid.org/0009-0007-9859-2188"]},"institutions":[{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Andrea Francesco Benvenuto","raw_affiliation_strings":["Department of Experimental Oncology, European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Experimental Oncology, European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milano, Italy","institution_ids":["https://openalex.org/I6141010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069822222","display_name":"Sara Sigismund","orcid":"https://orcid.org/0000-0002-1396-4453","observed_orcids":["https://orcid.org/0000-0002-1396-4453"]},"institutions":[{"id":"https://openalex.org/I189158943","display_name":"University of Milan","ror":"https://ror.org/00wjc7c48","country_code":"IT","type":"education","lineage":["https://openalex.org/I189158943"]},{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Sara Sigismund","raw_affiliation_strings":["Department of Experimental Oncology, European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milano, Italy; Department of Oncology and Hematology-Oncology, Universit\u00e0 degli Studi di Milano, Via Santa Sofia 9/1, 20122 Milano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Experimental Oncology, European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milano, Italy; Department of Oncology and Hematology-Oncology, Universit\u00e0 degli Studi di Milano, Via Santa Sofia 9/1, 20122 Milano, Italy","institution_ids":["https://openalex.org/I189158943","https://openalex.org/I6141010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010179729","display_name":"Federica Marocchi","orcid":"https://orcid.org/0000-0002-5610-5499","observed_orcids":["https://orcid.org/0000-0002-5610-5499"]},"institutions":[{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Federica Marocchi","raw_affiliation_strings":["Department of Experimental Oncology, European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Experimental Oncology, European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milano, Italy","institution_ids":["https://openalex.org/I6141010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028673758","display_name":"Luisa Lanfrancone","orcid":"https://orcid.org/0000-0002-4523-3815","observed_orcids":["https://orcid.org/0000-0002-4523-3815"]},"institutions":[{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]},{"id":"https://openalex.org/I93860229","display_name":"Politecnico di Milano","ror":"https://ror.org/01nffqt88","country_code":"IT","type":"education","lineage":["https://openalex.org/I93860229"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Luisa Lanfrancone","raw_affiliation_strings":["Department of Experimental Oncology, European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milano, Italy; Laboratory of Innovative approaches for tissue engineering and drug delivery Joint Research Platform \"ONCO-TECH LAB - Modeling and Applications for Human Health\", Politecnico di Milano - European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milano, Italy. Electronic address: luisa.lanfrancone@ieo.it"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Experimental Oncology, European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milano, Italy; Laboratory of Innovative approaches for tissue engineering and drug delivery Joint Research Platform \"ONCO-TECH LAB - Modeling and Applications for Human Health\", Politecnico di Milano - European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milano, Italy. Electronic address: luisa.lanfrancone@ieo.it","institution_ids":["https://openalex.org/I6141010","https://openalex.org/I93860229"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5024719839","display_name":"Francesca Baldelli Bombelli","orcid":"https://orcid.org/0000-0001-8138-9246","observed_orcids":["https://orcid.org/0000-0001-8138-9246"]},"institutions":[{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]},{"id":"https://openalex.org/I93860229","display_name":"Politecnico di Milano","ror":"https://ror.org/01nffqt88","country_code":"IT","type":"education","lineage":["https://openalex.org/I93860229"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Francesca Baldelli Bombelli","raw_affiliation_strings":["Department of Chemistry, Materials, and Chemical Engineering \"Giulio Natta\", Politecnico di Milano, Via E. Bassini 6, 20133 Milano, Italy; Laboratory of Innovative approaches for tissue engineering and drug delivery Joint Research Platform \"ONCO-TECH LAB - Modeling and Applications for Human Health\", Politecnico di Milano - European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milano, Italy. Electronic address: francesca.baldelli@polimi.it"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Materials, and Chemical Engineering \"Giulio Natta\", Politecnico di Milano, Via E. Bassini 6, 20133 Milano, Italy; Laboratory of Innovative approaches for tissue engineering and drug delivery Joint Research Platform \"ONCO-TECH LAB - Modeling and Applications for Human Health\", Politecnico di Milano - European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milano, Italy. Electronic address: francesca.baldelli@polimi.it","institution_ids":["https://openalex.org/I6141010","https://openalex.org/I93860229"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5024719839","https://openalex.org/A5028673758"],"corresponding_institution_ids":["https://openalex.org/I6141010","https://openalex.org/I93860229"],"apc_list":{"value":4440,"currency":"USD","value_usd":4440},"apc_paid":{"value":4440,"currency":"USD","value_usd":4440},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.49078197,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"398","issue":null,"first_page":"115275","last_page":"115275"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-melanoma","display_name":"metastatic melanoma","score":0.8930000066757202},{"id":"https://openalex.org/keywords/plga-nanoparticles","display_name":"PLGA nanoparticles","score":0.9919999837875366},{"id":"https://openalex.org/keywords/dual-drug-delivery","display_name":"dual drug delivery","score":0.7369999885559082},{"id":"https://openalex.org/keywords/trametinib","display_name":"trametinib","score":0.890999972820282},{"id":"https://openalex.org/keywords/alisertib","display_name":"alisertib","score":0.8679999709129333},{"id":"https://openalex.org/keywords/mek-inhibitors","display_name":"MEK inhibitors","score":0.9279999732971191},{"id":"https://openalex.org/keywords/aurora-a-kinase-inhibitor","display_name":"Aurora A kinase inhibitor","score":0.9800000190734863},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.6169999837875366},{"id":"https://openalex.org/keywords/endocytosis","display_name":"endocytosis","score":0.7200000286102295},{"id":"https://openalex.org/keywords/macropinocytosis","display_name":"macropinocytosis","score":0.9940000176429749},{"id":"https://openalex.org/keywords/recycling-endosomes","display_name":"recycling endosomes","score":0.7990000247955322},{"id":"https://openalex.org/keywords/cell-to-cell-spread","display_name":"cell-to-cell transmission","score":0.7889999747276306},{"id":"https://openalex.org/keywords/transcytosis","display_name":"transcytosis","score":0.8050000071525574},{"id":"https://openalex.org/keywords/patient-derived-spheroids","display_name":"patient-derived spheroids","score":0.8389999866485596},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.9240000247955322},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.6330000162124634},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.4490000009536743}],"concepts":[{"id":"https://openalex.org/C18150654","wikidata":"https://www.wikidata.org/wiki/Q17153796","display_name":"Nanocarriers","level":3,"score":0.7815999984741211},{"id":"https://openalex.org/C2777807558","wikidata":"https://www.wikidata.org/wiki/Q4914764","display_name":"Biodistribution","level":3,"score":0.6219000220298767},{"id":"https://openalex.org/C28005876","wikidata":"https://www.wikidata.org/wiki/Q189814","display_name":"Endocytosis","level":3,"score":0.5622000098228455},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5390999913215637},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5254999995231628},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.5200999975204468},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5174999833106995},{"id":"https://openalex.org/C139770010","wikidata":"https://www.wikidata.org/wiki/Q1339807","display_name":"Internalization","level":3,"score":0.5146999955177307},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5091999769210815},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.5026999711990356},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.4952000081539154},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.48500001430511475},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.48190000653266907},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.44859999418258667},{"id":"https://openalex.org/C110121322","wikidata":"https://www.wikidata.org/wiki/Q865811","display_name":"Distribution (mathematics)","level":2,"score":0.4189999997615814},{"id":"https://openalex.org/C79879829","wikidata":"https://www.wikidata.org/wiki/Q5571762","display_name":"Intracellular","level":2,"score":0.41190001368522644},{"id":"https://openalex.org/C15083742","wikidata":"https://www.wikidata.org/wiki/Q261659","display_name":"Nanomedicine","level":3,"score":0.3463999927043915},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.3314000070095062},{"id":"https://openalex.org/C13245373","wikidata":"https://www.wikidata.org/wiki/Q3715494","display_name":"Drug carrier","level":3,"score":0.3228999972343445},{"id":"https://openalex.org/C133936738","wikidata":"https://www.wikidata.org/wiki/Q643839","display_name":"Multiple drug resistance","level":3,"score":0.3093999922275543},{"id":"https://openalex.org/C149172746","wikidata":"https://www.wikidata.org/wiki/Q2585693","display_name":"Efficacy","level":3,"score":0.30410000681877136},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.2955999970436096},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.2883000075817108},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.27810001373291016},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.26589998602867126},{"id":"https://openalex.org/C19831878","wikidata":"https://www.wikidata.org/wiki/Q659446","display_name":"Therapeutic index","level":3,"score":0.2531999945640564}],"mesh":[{"descriptor_ui":"D000077182","descriptor_name":"Polylactic Acid-Polyglycolic Acid Copolymer","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D004337","descriptor_name":"Drug Carriers","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011728","descriptor_name":"Pyridones","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011728","descriptor_name":"Pyridones","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D011728","descriptor_name":"Pyridones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011744","descriptor_name":"Pyrimidinones","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011744","descriptor_name":"Pyrimidinones","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D011744","descriptor_name":"Pyrimidinones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014018","descriptor_name":"Tissue Distribution","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D019344","descriptor_name":"Lactic Acid","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053758","descriptor_name":"Nanoparticles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D053758","descriptor_name":"Nanoparticles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1016/j.jconrel.2026.115275","doi":"https://doi.org/10.1016/j.jconrel.2026.115275","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jconrel.2026.115275","pdf_url":"https://www.sciencedirect.com/science/article/pii/S0168365926006796/pdf","source":{"id":"https://openalex.org/S161954266","display_name":"Journal of Controlled Release","issn_l":"0168-3659","issn":["0168-3659","1873-4995"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Controlled Release","raw_type":"journal-article"},{"id":"pmid:42633845","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42633845","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of controlled release : official journal of the Controlled Release Society","raw_type":"Journal Article"},{"id":"pmh:oai:re.public.polimi.it:11311/1330268","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/11311/1330268","pdf_url":"https://re.public.polimi.it/bitstream/11311/1330268/1/1-s2.0-S0168365926006796-main.pdf","source":{"id":"https://openalex.org/S4306400312","display_name":"Virtual Community of Pathological Anatomy (University of Castilla La Mancha)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I79189158","host_organization_name":"University of Castilla-La Mancha","host_organization_lineage":["https://openalex.org/I79189158"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1016/j.jconrel.2026.115275","doi":"https://doi.org/10.1016/j.jconrel.2026.115275","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jconrel.2026.115275","pdf_url":"https://www.sciencedirect.com/science/article/pii/S0168365926006796/pdf","source":{"id":"https://openalex.org/S161954266","display_name":"Journal of Controlled Release","issn_l":"0168-3659","issn":["0168-3659","1873-4995"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Controlled Release","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1864982059","display_name":null,"funder_award_id":"PNCE3-2022-23683266","funder_id":"https://openalex.org/F4320321781","funder_display_name":"Ministero della Salute"},{"id":"https://openalex.org/G231133531","display_name":null,"funder_award_id":"PRIN2022","funder_id":"https://openalex.org/F7311471023","funder_display_name":"NextGenerationEU"},{"id":"https://openalex.org/G255694563","display_name":null,"funder_award_id":"5\u00d71000","funder_id":"https://openalex.org/F4320323054","funder_display_name":"Associazione Italiana per la Ricerca sul Cancro"},{"id":"https://openalex.org/G3195958759","display_name":null,"funder_award_id":"T4-AN-09","funder_id":"https://openalex.org/F4320321781","funder_display_name":"Ministero della Salute"},{"id":"https://openalex.org/G387172998","display_name":null,"funder_award_id":"\u201c5\u00d71000\u201d","funder_id":"https://openalex.org/F4320321781","funder_display_name":"Ministero della Salute"},{"id":"https://openalex.org/G5911110335","display_name":null,"funder_award_id":"PRIN2022","funder_id":"https://openalex.org/F4320321781","funder_display_name":"Ministero della Salute"},{"id":"https://openalex.org/G6229344744","display_name":null,"funder_award_id":"24415","funder_id":"https://openalex.org/F4320323054","funder_display_name":"Associazione Italiana per la Ricerca sul Cancro"},{"id":"https://openalex.org/G7039972366","display_name":null,"funder_award_id":"E3-2022-23683266","funder_id":"https://openalex.org/F4320321781","funder_display_name":"Ministero della Salute"}],"funders":[{"id":"https://openalex.org/F3151377329","display_name":"Fondazione AIRC per la ricerca sul cancro ETS","ror":null},{"id":"https://openalex.org/F4320318178","display_name":"Fondazione Istituto Europeo di Oncologia e Centro Cardiologico Monzino","ror":"https://ror.org/02yjmtx54"},{"id":"https://openalex.org/F4320321781","display_name":"Ministero della Salute","ror":"https://ror.org/00789fa95"},{"id":"https://openalex.org/F4320322823","display_name":"Fondazione Umberto Veronesi","ror":"https://ror.org/041g7jm83"},{"id":"https://openalex.org/F4320323054","display_name":"Associazione Italiana per la Ricerca sul Cancro","ror":"https://ror.org/02g2x7380"},{"id":"https://openalex.org/F4320324289","display_name":"Worldwide Cancer Research","ror":"https://ror.org/031tfbz57"},{"id":"https://openalex.org/F4320334322","display_name":"HORIZON EUROPE Framework Programme","ror":null},{"id":"https://openalex.org/F7311471023","display_name":"NextGenerationEU","ror":null}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7204028830.pdf","grobid_xml":"https://content.openalex.org/works/W7204028830.grobid-xml"},"referenced_works_count":77,"referenced_works":["https://openalex.org/W1599556954","https://openalex.org/W1696775091","https://openalex.org/W1971750711","https://openalex.org/W1992252639","https://openalex.org/W2055624262","https://openalex.org/W2096387850","https://openalex.org/W2116677194","https://openalex.org/W2151136040","https://openalex.org/W2153409108","https://openalex.org/W2160766792","https://openalex.org/W2207662183","https://openalex.org/W2254594392","https://openalex.org/W2343596022","https://openalex.org/W2351409154","https://openalex.org/W2465561570","https://openalex.org/W2469418432","https://openalex.org/W2520107693","https://openalex.org/W2586189939","https://openalex.org/W2601850155","https://openalex.org/W2626300607","https://openalex.org/W2735449222","https://openalex.org/W2735863468","https://openalex.org/W2771784673","https://openalex.org/W2772878912","https://openalex.org/W2774001339","https://openalex.org/W2776012678","https://openalex.org/W2783914781","https://openalex.org/W2791484514","https://openalex.org/W2800202257","https://openalex.org/W2886855629","https://openalex.org/W2890752806","https://openalex.org/W2912456393","https://openalex.org/W2947338182","https://openalex.org/W2948155539","https://openalex.org/W2971567983","https://openalex.org/W2995147378","https://openalex.org/W2998882776","https://openalex.org/W3008785175","https://openalex.org/W3019857594","https://openalex.org/W3025080581","https://openalex.org/W3092607059","https://openalex.org/W3099815570","https://openalex.org/W3134254717","https://openalex.org/W3135875197","https://openalex.org/W3136752605","https://openalex.org/W3171648992","https://openalex.org/W3181653622","https://openalex.org/W3205524139","https://openalex.org/W4200113945","https://openalex.org/W4200168827","https://openalex.org/W4206907302","https://openalex.org/W4292689521","https://openalex.org/W4315700889","https://openalex.org/W4327609524","https://openalex.org/W4362460305","https://openalex.org/W4365148379","https://openalex.org/W4367627080","https://openalex.org/W4375947164","https://openalex.org/W4377287007","https://openalex.org/W4384819462","https://openalex.org/W4384819865","https://openalex.org/W4388532660","https://openalex.org/W4390662499","https://openalex.org/W4391309841","https://openalex.org/W4391752562","https://openalex.org/W4394963538","https://openalex.org/W4400981945","https://openalex.org/W4401169134","https://openalex.org/W4401497204","https://openalex.org/W4404195837","https://openalex.org/W4405185023","https://openalex.org/W4405362694","https://openalex.org/W4408245101","https://openalex.org/W4409152771","https://openalex.org/W4409700584","https://openalex.org/W4410508493","https://openalex.org/W4412440977"],"related_works":["https://openalex.org/W3139306302","https://openalex.org/W2591861696","https://openalex.org/W3048940241","https://openalex.org/W4280611069","https://openalex.org/W2207414328","https://openalex.org/W4386100373","https://openalex.org/W4400735597","https://openalex.org/W4317624850","https://openalex.org/W1907091142","https://openalex.org/W4414418738"],"abstract_inverted_index":{"Metastatic":[0],"melanoma":[1],"remains":[2],"a":[3,32,84,91,115,148,186,206,232],"critical":[4],"clinical":[5],"challenge":[6],"due":[7],"to":[8,40,118,175,204,216,237],"high":[9],"transcriptional":[10],"plasticity":[11],"and":[12,80,129,169,194,219,246],"the":[13,17,22,45,120,154,180,228,239],"physical":[14],"barriers":[15],"of":[16,24,48,64,162,179,242],"tumor":[18,145,167,222],"microenvironment":[19],"that":[20,71,89],"limit":[21],"efficacy":[23,43],"standard":[25],"therapies.":[26],"In":[27,103,134],"this":[28],"study,":[29],"we":[30,69,184],"present":[31],"microfluidic-engineered":[33],"poly(lactic-co-glycolic":[34],"acid)":[35],"nanoparticle":[36],"(PLGA-NPs)":[37],"platform":[38,230],"designed":[39],"maximize":[41],"therapeutic":[42],"through":[44],"precise":[46],"co-encapsulation":[47],"synergistic":[49,209],"drug":[50,132],"combinations.":[51],"These":[52],"monodisperse":[53],"nanocarriers":[54],"exhibit":[55],"rapid,":[56],"dose-dependent":[57],"internalization":[58],"across":[59],"diverse":[60],"patient-derived":[61,105,140],"models,":[62],"independent":[63],"their":[65],"mutational":[66],"background.":[67],"Mechanistically,":[68],"demonstrate":[70],"PLGA-NPs":[72,229],"uptake":[73],"is":[74],"primarily":[75],"mediated":[76],"by":[77,83],"dynamin-dependent":[78],"endocytosis":[79],"macropinocytosis,":[81],"followed":[82],"dynamic":[85],"intracellular":[86,100],"trafficking":[87],"route":[88],"reaches":[90],"steady-state":[92],"distribution":[93],"within":[94],"recycling":[95],"endosomes,":[96],"thereby":[97],"enabling":[98],"prolonged":[99,171],"cargo":[101],"retention.":[102],"3D":[104],"spheroids,":[106],"these":[107,225],"nanoparticles":[108],"exploit":[109],"active":[110],"cell-to-cell":[111],"transfer":[112],"consistent":[113],"with":[114],"transcytosis-like":[116],"mechanism":[117],"penetrate":[119],"poorly":[121],"accessible":[122],"central":[123],"core,":[124],"effectively":[125,212],"bypassing":[126],"tissue-level":[127],"resistance":[128,215],"considerably":[130],"enhancing":[131],"efficacy.":[133],"vivo":[135],"biodistribution":[136],"in":[137],"orthotopically":[138],"transplanted":[139],"xenografts":[141],"confirmed":[142],"highly":[143],"efficient":[144],"targeting,":[146],"while":[147],"strategic":[149],"dose-modulation":[150],"approach":[151],"successfully":[152],"optimized":[153,203],"tumor-to-liver":[155],"accumulation":[156],"ratio.":[157],"Therapeutically,":[158],"twice-weekly":[159],"intravenous":[160],"administration":[161,178],"trametinib-loaded":[163],"NPs":[164],"achieved":[165],"superior":[166],"regression":[168],"significantly":[170],"overall":[172],"survival":[173],"compared":[174],"daily":[176],"oral":[177],"free":[181],"drug.":[182],"Furthermore,":[183],"developed":[185],"dual-drug":[187],"delivery":[188],"system":[189],"co-loading":[190],"trametinib,":[191],"MEK":[192],"inhibitor,":[193],"alisertib,":[195],"Aurora":[196],"kinase":[197],"A":[198],"inhibitor.":[199],"This":[200],"formulation":[201],"was":[202],"maintain":[205],"previously":[207],"established":[208],"ratio":[210],"which":[211],"overcomes":[213],"acquired":[214],"standard-of-care":[217],"therapies":[218],"induces":[220],"durable":[221],"regression.":[223],"Collectively,":[224],"findings":[226],"establish":[227],"as":[231],"robust,":[233],"clinically":[234],"relevant":[235],"strategy":[236],"enhance":[238],"pharmacokinetic":[240],"profile":[241],"treatments":[243],"for":[244],"metastatic":[245],"drug-resistant":[247],"melanoma.":[248]},"counts_by_year":[],"updated_date":"2026-10-23T09:35:12.469056","created_date":"2026-08-24T00:00:00"}